Catalyst Wire Dossier Catalyst Wire Dossier

IL-2 expressing, attenuated Salmonella Typhimurium

interleukin-2 expressing attenuated Salmonella Typhimurium
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-2 expressing, attenuated Salmonella Typhimurium, covering 2020-07-20 to 2020-07-20. Get the full timeline:

Most recent: Clinical Trial Update: IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread [Phase 1]

See pricing